Bearish
PATENT—Fed. Cir.: Validity of Teva Pharma’s migraine antibody patents reinstated, judgment for Eli Lilly reversed
The Federal Circuit has reinstated the validity of Teva Pharmaceutical's migraine antibody patents and reversed a judgment in favor of Eli Lilly. This...